Washington, DC (UroToday.com) At the second kidney cancer session at the 2019 Society for Urologic Oncology Annual Meeting, Dr. Sumanta Pal addressed the utility of observational data in driving treatment decisions for patients with metastatic renal cell carcinoma.
Non-Accredited